Idera Pharmaceuticals Inc (IDRA)

[Seel]

Finished the conference call. Catalyst quiet for a while, other than conferences. I didn't hear anything overtly negative. They will need to land a partner or two but that isn't near term concern. Once the knife stops falling, accumulation this year will surely pay off next year. I'm still a fan, though the next few quarters are likely to be boring as hell.